Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362480956> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- W4362480956 abstract "<div>Abstract<p>Barrett's esophagus (BE), a recognized risk factor for esophageal adenocarcinoma (EAC), is routinely managed with proton pump inhibitors (PPIs) when symptomatic. Several lines of evidence suggest that PPIs may prevent malignant transformation. Chronic use of other common drugs, namely, statins nonsteroidal anti-inflammatory drugs (NSAIDs) and metformin, may also interfere with BE carcinogenesis, but confirmatory evidence is lacking. We identified 1,943 EAC cases and 19,430 controls (matched 10:1) between 2007 and 2013 that met our specified inclusion criteria in the SEER–Medicare database. Conditional logistic regression was used to generate odds ratios (OR) and 95% confidence intervals (95% CI). Wald χ<sup>2</sup> tests were used to assess significance of covariates. Compared with controls, EAC cases had a higher prevalence of BE (26.2%). Use of PPIs, NSAIDs, statins, or metformin reduced the odds of EAC (PPIs: 0.10; 95% CI, 0.09–0.12; NSAIDs: 0.62; 95% CI, 0.51–0.74; statins: 0.15; 95% CI, 0.13–0.17; metformin: 0.76; 95% CI, 0.62–0.93). When stratified by BE, these associations persisted, though no association was found between NSAID use and EAC risk for participants with BE. Dual use of PPIs with NSAIDs or statins, and NSAID, statin, or metformin use alone also showed significant EAC risk reduction among all participants and those without BE. Use of PPIs alone and with NSAIDs, statins, or metformin was associated with reduced risk of EAC; however, a history of BE may diminish drug efficacy. These results indicate that common pharmacologic agents alone or in combination may decrease EAC development.</p><p><b>Prevention Relevance:</b> The use of common drugs, such as proton pump inhibitors, statins, non-steroidal anti-inflammatory drugs, or metformin, may reduce one's risk of developing esophageal adenocarcinoma. These results suggest that repurposing agents often used for common chronic conditions may be a new strategy for cancer prevention efforts.</p></div>" @default.
- W4362480956 created "2023-04-05" @default.
- W4362480956 creator A5004061795 @default.
- W4362480956 creator A5008765045 @default.
- W4362480956 creator A5020471320 @default.
- W4362480956 creator A5067186924 @default.
- W4362480956 date "2023-04-03" @default.
- W4362480956 modified "2023-09-27" @default.
- W4362480956 title "Data from Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER–Medicare Analysis" @default.
- W4362480956 doi "https://doi.org/10.1158/1940-6207.c.6546997" @default.
- W4362480956 hasPublicationYear "2023" @default.
- W4362480956 type Work @default.
- W4362480956 citedByCount "0" @default.
- W4362480956 crossrefType "posted-content" @default.
- W4362480956 hasAuthorship W4362480956A5004061795 @default.
- W4362480956 hasAuthorship W4362480956A5008765045 @default.
- W4362480956 hasAuthorship W4362480956A5020471320 @default.
- W4362480956 hasAuthorship W4362480956A5067186924 @default.
- W4362480956 hasBestOaLocation W43624809562 @default.
- W4362480956 hasConcept C121608353 @default.
- W4362480956 hasConcept C126322002 @default.
- W4362480956 hasConcept C143998085 @default.
- W4362480956 hasConcept C156957248 @default.
- W4362480956 hasConcept C2779306644 @default.
- W4362480956 hasConcept C2779742542 @default.
- W4362480956 hasConcept C2780323712 @default.
- W4362480956 hasConcept C44249647 @default.
- W4362480956 hasConcept C71924100 @default.
- W4362480956 hasConcept C90924648 @default.
- W4362480956 hasConceptScore W4362480956C121608353 @default.
- W4362480956 hasConceptScore W4362480956C126322002 @default.
- W4362480956 hasConceptScore W4362480956C143998085 @default.
- W4362480956 hasConceptScore W4362480956C156957248 @default.
- W4362480956 hasConceptScore W4362480956C2779306644 @default.
- W4362480956 hasConceptScore W4362480956C2779742542 @default.
- W4362480956 hasConceptScore W4362480956C2780323712 @default.
- W4362480956 hasConceptScore W4362480956C44249647 @default.
- W4362480956 hasConceptScore W4362480956C71924100 @default.
- W4362480956 hasConceptScore W4362480956C90924648 @default.
- W4362480956 hasLocation W43624809561 @default.
- W4362480956 hasLocation W43624809562 @default.
- W4362480956 hasOpenAccess W4362480956 @default.
- W4362480956 hasPrimaryLocation W43624809561 @default.
- W4362480956 hasRelatedWork W1545000863 @default.
- W4362480956 hasRelatedWork W1973855633 @default.
- W4362480956 hasRelatedWork W1984235851 @default.
- W4362480956 hasRelatedWork W2033313326 @default.
- W4362480956 hasRelatedWork W2072752555 @default.
- W4362480956 hasRelatedWork W2084845148 @default.
- W4362480956 hasRelatedWork W2317313649 @default.
- W4362480956 hasRelatedWork W2464808367 @default.
- W4362480956 hasRelatedWork W2996523451 @default.
- W4362480956 hasRelatedWork W4292182750 @default.
- W4362480956 isParatext "false" @default.
- W4362480956 isRetracted "false" @default.
- W4362480956 workType "article" @default.